Annexon
Annexon is a California-based biopharmaceutical company that develops and markets complement medicines to treat autoimmune, neurodegenerative and ophthalmic disorders.
Business Model:
Revenue: $0
Employees: 51-200
Detailed Annexon Information
Geographic Data
Address: 1400 Sierra Point
City: Brisbane
State: CA
Zip: 94005
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$130M
Raised Total:$384M
Social
Metrics
3,556,745Website Global Rank
3,863Website Monthly Traffic
Twitter Followers
Description
Annexon is a California-based biopharmaceutical company that develops and markets complement medicines to treat autoimmune, neurodegenerative and ophthalmic disorders.
Contact Phone:
+16508225500
Contact Email:
Annexon went public on 7/24/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/24/2020
IPO Valuation:
$612M
Ticker Symbol:
ANNX
IPO Price:
$17/share
Amount Raised:
$251M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
